Agile Therapeutics Inc. said it raised $13.8 million in gross proceeds after underwriters of a previously announced stock offering fully exercised their overallotment option.
The Princeton, N.J.-based women's healthcare company sold an additional 1,894,736 shares at 95 cents each, bringing the total number of stock sold to 14,526,315.
Oppenheimer & Co. Inc. acted as the sole book-running manager for the offering, while H.C. Wainwright & Co. LLC acted as lead manager.
